A Congiu
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 5
- Acute Myeloid Leukemia Research 4
- Multiple Myeloma Research and Treatments 3
-
- Lymphoma Diagnosis and Treatment 12
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 9
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 3
-
- Acute Lymphoblastic Leukemia research 5
-
- Childhood Cancer Survivors' Quality of Life 2
- Co-authors
- Angelo Michele CarellaGino SantiniS NatiP CoserE DamasioPatrizio MazzaL MangoniGiovanna Meloni
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
A Congiu
23 papers receiving 503 citations
Peers
Comparison fields: 5 of 48
- Hematology 225
- Pathology and Forensic Medicine 278
- Genetics 152
- Oncology 224
- Neurology 120
Countries citing papers authored by A Congiu
This map shows the geographic impact of A Congiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Congiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Congiu more than expected).
Fields of papers citing papers by A Congiu
This network shows the impact of papers produced by A Congiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Congiu. The network helps show where A Congiu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Congiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 0 | |
| 2 | 2006 | 62 | |
| 3 | 2006 | 1 | |
| 4 | 2004 | 7 | |
| 5 | 2002 | 0 | |
| 6 | 2001 | 2 | |
| 7 | 2000 | 30 | |
| 8 | Fludarabine in combination: An effective therapy for relapsed or refractory low-grade non-Hodgkin's lymphoma (LGL): A multicentre experience | 2000 | 1 |
| 9 | 1999 | 7 | |
| 10 | 1994 | 31 | |
| 11 | 1991 | 3 | |
| 12 | 1991 | 21 | |
| 13 | Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol. | 1991 | 73 |
| 14 | Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report. | 1991 | 11 |
| 15 | Lymphoblastic lymphoma (LBL) and acute lymphoblastic leukaemia (ALL) in adults: relationships and therapeutic perspectives. | 1989 | 2 |
| 16 | 1988 | 136 | |
| 17 | Autologous bone marrow transplantation for acute leukemia in remission. The Genoa experience. | 1988 | 5 |
| 18 | 1987 | 9 | |
| 19 | 1985 | 32 | |
| 20 | 1985 | 52 |
About A Congiu
A Congiu is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Neurology, having authored 25 papers that have together received 531 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Hematology (225 citations), Pathology and Forensic Medicine (278 citations), Genetics (152 citations), Oncology (224 citations) and Neurology (120 citations). A Congiu has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Angelo Michele Carella, Gino Santini, S Nati, P Coser, E Damasio, Patrizio Mazza, L Mangoni, Giovanna Meloni, Giuseppe Visani and Giuseppe Cimino. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, Cancer and Brazilian Journal of Medical and Biological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.